200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study

200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study

Https://www.otplinks.com

Based on the transcript flow, here’s a clean YouTube description with chapter timestamps. The transcript itself doesn’t include timecodes, so these are estimated from speaking pace and topic position.

A GLP-1 Death_ Chrissy Metz & a Stunning Harvard Study.txt

More than 200 deaths in the UK have now been reported in association with GLP-1 medications, including the heartbreaking death of a 19-year-old woman taking tirzepatide.

But the headline does NOT tell the whole story.

Today, we unpack what those 216 reports actually mean, what investigators found in the death of Josephine Nassar, and why adverse-event reports are very different from proving a medication caused a death.

Plus, This Is Us star Chrissy Metz reveals she is using a GLP-1 to treat obesity, and I think what she did deserves a lot more respect than she’s getting.

Then we dig into a stunning new Harvard working paper examining what happened to women’s employment and relationship outcomes after starting GLP-1 treatment, and Starbucks becomes the latest major employer to pull GLP-1 coverage for obesity.

This is a BIG episode.

⏱️ CHAPTERS

00:00 The GLP-1 headlines you need to know
01:40 VoaFit / MyLevel
03:30 200+ GLP-1 deaths reported in the UK
04:25 The tragic death of 19-year-old Josephine Nassar
09:40 The hidden heart condition found after her death
12:30 Did tirzepatide contribute to her death?
15:35 What the UK’s 216 GLP-1 death reports actually mean
19:15 Pancreatitis and how regulators identify real safety signals
22:35 Chrissy Metz reveals she’s taking a GLP-1
24:35 Why Chrissy Metz’s decision to tell the truth was incredibly brave
27:05 Harvard’s stunning “Obesity Penalty” study
30:30 Starbucks drops GLP-1 coverage for obesity
33:10 What happens when employers stop paying for these drugs?
34:15 Final thoughts and your call to action

If you’ve lost significant weight, I want to hear from you: Did people start treating you differently?

And if your employer stopped covering your GLP-1, would you consider changing jobs to keep access to treatment?

👇 Drop your experience in the comments.

🔗 Keep up with everything On The Pen:
linktr.ee/manonthemounjaro

On The Pen brings you the stories and information that empower you to have better conversations with your doctor.

Subscribe and join us live every Monday, Wednesday and Friday at 11 AM Central / 12 PM Eastern.

#GLP1 #Mounjaro #Zepbound #Ozempic #Wegovy #Tirzepatide #WeightLoss #Obesity #ChrissyMetz

If you give me the actual final runtime of the uploaded video, I can tighten those timestamps much closer to the real chapter breaks.



Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(206)

GLP-1 Coverage Is COLLAPSING in 2027

GLP-1 Coverage Is COLLAPSING in 2027

GLP-1 access is getting tighter just as obesity treatment is becoming more effective, more affordable, and more important to public health.In this episode of the On The Pen Podcast, Dave Knapp breaks ...

26 Aug 34min

$50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”

$50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”

Could GLP-1 medications eventually cost just $40 to $50 per month? Hims & Hers CEO Andrew Dudum thinks so, and if he’s right, it could completely change access to obesity treatment in America.But gett...

18 Aug 45min

Eli Lilly Earnings Call Recap: Retatrutide News

Eli Lilly Earnings Call Recap: Retatrutide News

https://www.otplinks.com

7 Aug 59min

Novo Nordisk Warned us For Years About Synthesized Semaglutide. Now They Want In.

Novo Nordisk Warned us For Years About Synthesized Semaglutide. Now They Want In.

Novo Nordisk has spent years warning patients, regulators, lawmakers, and courts about the risks of synthetic semaglutide. Now, as patents begin to expire and China’s pharmaceutical industry becomes i...

4 Aug 18min

Retatrutide Biologic Battle: The Story Gets Bigger

Retatrutide Biologic Battle: The Story Gets Bigger

https://www.otplinks.comhttps://www.voafit.com/otpEpisode Referenced: https://www.youtube.com/watch?v=K8kaSoFCZ0c&t=41sThe retatrutide biologic fight is bigger than folks understand.This breakdown cov...

28 Jul 20min

GLP-1 Showdown: Inside The High Stakes War over Patients

GLP-1 Showdown: Inside The High Stakes War over Patients

Novo Nordisk just declared legal war on Eli Lilly as the battle over GLP-1 patients intensifies. But just because patients are being fought over does not mean they are being fought for.In this episode...

22 Jul 27min

Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know

Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know

What happens when patients stop taking a GLP-1? New real-world data reveals that more than half eventually come back, and it may completely change the way we think about obesity treatment.In this week...

14 Jul 31min

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
rss-gukild-johaug
psykodrama
hvordan-har-du-det-mann
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
morten-ramm-lar-kakla-ga-til-du-sovner
foreldreradet
hjernesterk
rss-lopedrommen
g-punktet
rss-garne-damer
kjed-deg-i-sovn-verdens-kjedeligste-podcast
klimaks
treningsprat
hormonelle-frida
sinnsyn